President Joe Biden’s mention of ongoing marijuana reform efforts during his annual State of the Union address is considered a landmark achievement for MJ policy by political observers as well as stakeholders in the $34 billion U.S. cannabis industry.
But those keen to know exactly when the U.S. Drug Enforcement Administration will issue its highly anticipated response to health regulators’ revolutionary 2023 recommendation to move marijuana from Schedule 1 to Schedule 3 of the Controlled Substances Act remain frustrated.
ADVERTISEMENT
“Anyone who says they know is full of it,” Andrew Kline, a Denver-based senior counsel for Perkins Coie who co-chairs the law firm’s cannabis industry group, told MJBizDaily via email Monday.
“Only DEA/DOJ knows about timing,” he added. “And it’s a black box.”
It’s
Read full article on Marijuana Business Daily
